PATENT CLAIM ANALYSIS

Application Number: 16207916
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["544", "070000"]

Abstract:
The invention relates to 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives, their preparation and their use in medicine, particularly in the treatment of pain.

Claim (Index 24):
The compound according to  claim 1 , which has a structure according to general formula (IX) wherein R C  means \u2014H or \u2014OH; R 3  means -phenyl or -3-fluorophenyl; R 5  means C 1 -C 6 -alkyl, linear or branched, saturated, unsubstituted or monosubstituted with \u2014OH, \u2014CN, \u2014NH 2 , \u2014NHC(\u2550O)C 1 -C 4 -alkyl, \u2014NHS(\u2550O) 2 \u2014C 1 -C 4 -alkyl, or \u2014S(\u2550O) 2 \u2014C 1 -C 4 -alkyl; or 3-6-membered heterocycloalkyl, saturated, unsubstituted or substituted with \u2014OH; wherein said 3-6-membered heterocycloalkyl is optionally connected through \u2014CH 2 \u2014 or \u2014(CH 2 ) 2 \u2014; or a physiologically acceptable salt thereof.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 98.0
- Lexical Diversity: 1.13043
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11994001', '12700857', '12699451', '15125615', '12604691']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7950388909184924
- 35 USC 102 Novelty (BERT): 0.5427544724622212
- Combined Prediction Score: 0.7698104490728653
- Mean Citation Score: 376.134266
- Max Citation Score: 388.24194
- Similarity Product: 279.3404249817538

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test